Quick Answer
NeuroPace Inc reported Diluted EPS of $0.66 per share (loss) for fiscal year 2025.
NeuroPace Inc Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.66 | +29.0% |
| 2024 | -$0.93 | +26.8% |
| 2023 | -$1.27 | +33.5% |
| 2022 | -$1.91 | +12.0% |
| 2021 | -$2.17 | +98.2% |
| 2020 | -$117.85 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.11 | +42.1% | +57.7% |
| June 30, 2025 | -$0.26 | +0.0% | -23.8% |
| March 31, 2025 | -$0.21 | +34.4% | -10.5% |
| September 30, 2024 | -$0.19 | +32.1% | +26.9% |
| June 30, 2024 | -$0.26 | +27.8% | +18.8% |
| March 31, 2024 | -$0.32 | +22.0% | -14.3% |
| September 30, 2023 | -$0.28 | +41.7% | +22.2% |
| June 30, 2023 | -$0.36 | +30.8% | +12.2% |
- NeuroPace Inc showed an increase of +29.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, NeuroPace Inc’s diluted eps has grown by 99.4% (from $117.85 per share (loss) to $0.66 per share (loss)).
- The most recent figure is from NeuroPace Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: